Patent 10188732 was granted and assigned to Biogen on January, 2019 by the United States Patent and Trademark Office.
Aspects of the invention provide therapeutic recombinant protein preparations and methods of preparing therapeutic recombinant protein, which methods include contacting recombinant protein preparations with zwitterionic detergent at or above critical micelle concentration of the detergent.